Three new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury ...

Clinical Trial has Advanced to Fifth and Final Cohort at Maximum Dose of INSTASYL PH-762 in Skin Cancer Trial Positive Pathology Results at Maximum Dose: 100% Tumor Clearance (Complete Response) in ...

Couns. Bonnie Fokkens (Ward 6) and Graham Speck (Ward 5) say there’s an inability to debate the 2026 budget, the third under ...

Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the ...

Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments$32.6 million cash balance ...

HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful personalized insights, has reported its financial and operational results for the third ...